Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Anal Sci ; 38(12): 1457-1487, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36198988

ABSTRACT

Analytical processes involving sample preparation, separation, and quantifying analytes in complex mixtures are indispensable in modern-day analysis. Each step is crucial to enriching correct and informative results. Therefore, sample preparation is the critical factor that determines both the accuracy and the time consumption of a sample analysis process. Recently, several promising sample preparation approaches have been made available with environmentally friendly technologies with high performance. As a result of its many advantages, solid-phase extraction (SPE) is practiced in many different fields in addition to the traditional methods. The SPE is an alternative method to liquid-liquid extraction (LLE), which eliminates several disadvantages, including many organic solvents, a lengthy operation time and numerous steps, potential sources of error, and high costs. SPE advanced sorbent technology reorients with various functions depending on the structure of extraction sorbents, including reversed-phase, normal-phase, cation exchange, anion exchange, and mixed-mode. In addition, the commercial SPE systems are disposable. Still, with the continual developments, the restricted access materials (RAM) and molecular imprinted polymers (MIP) are fabricated to be active reusable extraction cartridges. This review will discuss all the theoretical and practical principles of the SPE techniques, focusing on packing materials, different forms, and performing factors in recent and future advances. The information about novel methodological and instrumental solutions in relation to different variants of SPE techniques, solid-phase microextraction (SPME), in-tube solid-phase microextraction (IT-SPME), and magnetic solid-phase extraction (MSPE) is presented. The integration of SPE with analytical chromatographic techniques such as LC and GC is also indicated. Furthermore, the applications of these techniques are discussed in detail along with their advantages in analyzing pharmaceuticals, biological samples, natural compounds, pesticides, and environmental pollutants, as well as foods and beverages.


Subject(s)
Pesticides , Solid Phase Extraction , Solid Phase Microextraction/methods , Solvents/chemistry , Polymers/chemistry
2.
Curr Alzheimer Res ; 18(10): 841-848, 2021.
Article in English | MEDLINE | ID: mdl-34879803

ABSTRACT

Neuroscience has long sought to develop methods that can "edit" or even "erase" memories, with the aim to provide treatments for memory-related neurological and psychiatric diseases such as anxiety and addiction. Current efforts are heavily focused on modifying cognitive behavioral therapy protocols or pharmacological treatments, but the efficacy and safety of these methods have been called into question by several studies. Advances in modern technology and the rapid emergence of techniques that can directly stimulate/alter neuronal activity, such as neuromodulation, have great potential in achieving the goal of memory modification for treating dementia such as Alzheimer's disease. However, more research and validation studies are required before these memory editing technologies can be applied clinically. In this mini-review, we compare and highlight the advantages and disadvantages of cognitive behavioral therapy, pharmacological methods, and neuromodulation techniques. We believe that neuromodulation techniques will play a key role in overcoming the challenges of translating memory-manipulating techniques to clinical applications.


Subject(s)
Alzheimer Disease , Cognitive Behavioral Therapy , Cognitive Dysfunction , Alzheimer Disease/psychology , Alzheimer Disease/therapy , Humans , Surveys and Questionnaires
3.
Curr Alzheimer Res ; 18(10): 831-840, 2021.
Article in English | MEDLINE | ID: mdl-34719364

ABSTRACT

Nitric oxide synthase (NOS) is well known for its involvement in the regulation of the nervous, cardiovascular, and immune systems. Neuronal NOS (nNOS) is the most characterized NOS among all the isoforms. It accounts for most of the production of nitric oxide (NO) in the nervous system required for synaptic transmission and neuroplasticity. Previous studies have described the localization of nNOS in specific brain regions of interest. There is substantial evidence in the literature suggesting that nNOS signaling has significant involvement in several disease pathologies. However, the association between brain nNOS expression profiles and disease remains largely unknown. In this review, we attempt to delineate the contribution of nNOS signaling in memory and mood disorders in order to achieve a better understanding of nNOS in disease modulation.


Subject(s)
Mood Disorders , Neurodegenerative Diseases , Nitric Oxide Synthase Type I , Humans , Mood Disorders/enzymology , Neurodegenerative Diseases/enzymology , Nitric Oxide/metabolism , Nitric Oxide Synthase Type I/metabolism
4.
Acta Neurochir (Wien) ; 152(4): 565-77, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20101419

ABSTRACT

INTRODUCTION: Major depressive disorder is one of the most disabling and common diagnoses amongst psychiatric disorders, with a current worldwide prevalence of 5-10% of the general population and up to 20-25% for the lifetime period. HISTORICAL PERSPECTIVE: Nowadays, conventional treatment includes psychotherapy and pharmacotherapy; however, more than 60% of the treated patients respond unsatisfactorily, and almost one fifth becomes refractory to these therapies at long-term follow-up. NONPHARMACOLOGICAL TECHNIQUES: Growing social incapacity and economic burdens make the medical community strive for better therapies, with fewer complications. Various nonpharmacological techniques like electroconvulsive therapy, vagus nerve stimulation, transcranial magnetic stimulation, lesion surgery, and deep brain stimulation have been developed for this purpose. DISCUSSION: We reviewed the literature from the beginning of the twentieth century until July 2009 and described the early clinical effects and main reported complications of these methods.


Subject(s)
Deep Brain Stimulation , Depressive Disorder, Major/therapy , Electroconvulsive Therapy , Psychosurgery , Transcranial Magnetic Stimulation , Vagus Nerve Stimulation , Animals , Brain Mapping , Chronic Disease , Depressive Disorder, Major/physiopathology , Dominance, Cerebral/physiology , Emotions/physiology , Humans , Outcome and Process Assessment, Health Care , Postoperative Complications/etiology , Postoperative Complications/physiopathology , Prefrontal Cortex/physiopathology , Recurrence , Retreatment , Solitary Nucleus/physiopathology , Vagus Nerve/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...